We are live on
!
Find out more
IIM
INTECH Investment Management Portfolio holdings
AUM
$10.2B
1-Year Est. Return
28.14%
This Fund
S&P 500
This Quarter
Est. Return
+15.26%
1 Year Est. Return
+28.14%
3 Year Est. Return
+94.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.7B
AUM Growth
+$949M
(+9.8%)
Cap. Flow
-$119M
Cap. Flow
% of AUM
-1.12%
Top 10 Holdings %
Top 10 Hldgs %
26.63%
Holding
2,728
New
207
Increased
842
Reduced
1,314
Closed
281
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Targa Resources
TRGP
|
+$34M |
| 2 |
General Motors
GM
|
+$28.5M |
| 3 |
FedEx
FDX
|
+$26.3M |
| 4 |
CBRE Group
CBRE
|
+$25.4M |
| 5 |
UnitedHealth
UNH
|
+$22.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$38M |
| 2 |
DexCom
DXCM
|
+$32.3M |
| 3 |
Iron Mountain
IRM
|
+$29.5M |
| 4 |
Walt Disney
DIS
|
+$19.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$18.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.59% |
| 2 | Financials | 13.46% |
| 3 | Consumer Discretionary | 12.31% |
| 4 | Healthcare | 10.42% |
| 5 | Industrials | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
CVRx
CVRX
$63.4M
| $59K | ﹤0.01% |
+10,031
| New | +$69.2K |
|
|
STLN
2402
Starling Oncology, Inc. Common Stock
STLN
$641M
| $58.7K | ﹤0.01% |
+28,614
| New | +$71.5K |
|
2403
PLAYSTUDIOS Inc
MYPS
$90.1M
| $58.6K | ﹤0.01% |
44,696
-19,490
| -30% | -$26.8K |
|
|
VOXR
2404
Vox Royalty Corp
VOXR
$347M
| $58.6K | ﹤0.01% |
+18,529
| New | +$61.1K |
|
2405
Nerdy
NRDY
$96.7M
| $58.3K | ﹤0.01% |
35,790
-11,125
| -24% | -$17.8K |
|
2406
DiaMedica Therapeutics
DMAC
$364M
| $56.2K | ﹤0.01% |
+14,415
| New | +$56.2K |
|
2407
Alector
ALEC
$199M
| $55.9K | ﹤0.01% |
39,915
-20,836
| -34% | -$26.1K |
|
2408
BARK
BARK
$101M
| $55.8K | ﹤0.01% |
3,169
-460
| -13% | -$10.6K |
|
2409
SunPower Inc
SPWR
$53.8M
| $55.6K | ﹤0.01% |
+30,233
| New | +$52.2K |
|
2410
eHealth
EHTH
$43.9M
| $55.3K | ﹤0.01% |
+12,704
| New | +$63.8K |
|
2411
Lexeo Therapeutics
LXEO
$378M
| $55K | ﹤0.01% |
13,682
+2,342
| +21% | +$7.7K |
|
2412
Outdoor Holding Co
POWW
$247M
| $54.3K | ﹤0.01% |
42,411
-16,874
| -28% | -$26.8K |
|
2413
Protalix BioTherapeutics
PLX
$198M
| $54K | ﹤0.01% |
+36,490
| New | +$74.7K |
|
2414
Nkarta
NKTX
$172M
| $53.4K | ﹤0.01% |
32,197
+3,405
| +12% | +$6.24K |
|
2415
BRC Inc
BRCC
$250M
| $52.6K | ﹤0.01% |
40,175
+67
| +0.2% | +$124 |
|
|
LFT
2416
Lument Finance Trust
LFT
$36.6M
| $52.4K | ﹤0.01% |
+23,705
| New | +$59.7K |
|
|
AIRJ
2417
Montana Technologies Corp
AIRJ
$429M
| $51.5K | ﹤0.01% |
+11,125
| New | +$51.1K |
|
2418
Zevia
ZVIA
$111M
| $51.3K | ﹤0.01% |
+15,926
| New | +$41.9K |
|
2419
Clarus
CLAR
$143M
| $49.9K | ﹤0.01% |
14,372
-6,815
| -32% | -$23.1K |
|
2420
Protara Therapeutics
TARA
$232M
| $48.8K | ﹤0.01% |
+16,111
| New | +$55.6K |
|
2421
Pulmonx
LUNG
$87.6M
| $48.7K | ﹤0.01% |
18,789
-4,895
| -21% | -$19.3K |
|
|
AVR
2422
Anteris Technologies
AVR
$867M
| $48.6K | ﹤0.01% |
+12,820
| New | +$52.1K |
|
|
TSE
2423
DELISTED
Trinseo
TSE
| $48.4K | ﹤0.01% |
+15,514
| New | +$51.1K |
|
2424
NET Power
NPWR
$134M
| $48.3K | ﹤0.01% |
19,541
-20,011
| -51% | -$42K |
|
|
RPT
2425
Rithm Property Trust
RPT
$93.7M
| $47.3K | ﹤0.01% |
+2,918
| New | +$47.5K |
|
Similar funds
ACA
GI
VPIM
RA
RI
HRCM
WAM
HI
INTECH Investment Management's Q2 2025 Portfolio in Review
As of Q2 2025, INTECH Investment Management held 2,728 positions worth $10.7B, up 9.8% from $9.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
INTECH Investment Management's Q2 2025 filing shows 207 new, 842 increased, 1,314 reduced and 281 closed positions. Its largest new stake was Magna International: 279,080 shares worth $10.8M. The largest sale was Merck, an estimated $38M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- INTECH Investment Management's largest Q2 2025 buy was Magna International: 279,080 shares worth $10.8M.
- INTECH Investment Management added most to Targa Resources in Q2 2025, an estimated $34M increase.
- INTECH Investment Management's biggest Q2 2025 reduction was Merck, cutting an estimated $38M.
- INTECH Investment Management fully exited Insmed in Q2 2025, selling an estimated $7.78M.
- INTECH Investment Management's ten largest holdings make up 27% of its $10.7B portfolio in Q2 2025.
- INTECH Investment Management opened 207 new positions and closed 281 in Q2 2025.
- INTECH Investment Management's portfolio value rose 9.8% quarter-over-quarter to $10.7B.
Based on INTECH Investment Management's 13F filing for Q2 2025, filed 8 Aug 2025.